Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Depreciation and Depletion (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Depreciation and Depletion for 6 consecutive years, with $21261.0 as the latest value for Q4 2021.

  • Quarterly Depreciation and Depletion fell 33.31% to $21261.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $116238.0 through Dec 2021, down 18.48% year-over-year, with the annual reading at $44045.0 for FY2025, 5.26% down from the prior year.
  • Depreciation and Depletion for Q4 2021 was $21261.0 at ENDRA Life Sciences, down from $29823.0 in the prior quarter.
  • The five-year high for Depreciation and Depletion was $45114.0 in Q3 2020, with the low at $14865.0 in Q2 2018.
  • Average Depreciation and Depletion over 5 years is $23460.2, with a median of $20091.0 recorded in 2018.
  • The sharpest move saw Depreciation and Depletion soared 126.37% in 2020, then plummeted 33.89% in 2021.
  • Over 5 years, Depreciation and Depletion stood at $15360.0 in 2017, then soared by 30.66% to $20070.0 in 2018, then increased by 4.16% to $20904.0 in 2019, then surged by 52.5% to $31878.0 in 2020, then crashed by 33.31% to $21261.0 in 2021.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $21261.0, $29823.0, and $33729.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.